Lifecore Biomedical, Inc.
LFCR
$7.90
$0.070.89%
NASDAQ
| 09/30/2025 | 05/25/2025 | 02/23/2025 | 11/24/2024 | 08/25/2024 | |
|---|---|---|---|---|---|
| Net Income | -9.99M | -1.15M | -14.77M | -6.57M | -16.23M |
| Total Depreciation and Amortization | 1.98M | 1.91M | 2.08M | 2.04M | 1.99M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 9.13M | 5.61M | 16.33M | 7.11M | 6.13M |
| Change in Net Operating Assets | 638.00K | -1.03M | -2.44M | -8.70M | 7.47M |
| Cash from Operations | 1.76M | 5.35M | 1.20M | -6.11M | -643.00K |
| Capital Expenditure | -1.74M | -2.10M | -5.46M | -2.47M | -3.39M |
| Sale of Property, Plant, and Equipment | -- | 0.00 | 7.00M | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1.74M | -2.10M | 1.54M | -2.47M | -3.39M |
| Total Debt Issued | 12.10M | 128.57M | -- | -1.91M | 1.91M |
| Total Debt Repaid | -12.33M | -128.80M | -6.23M | -11.43M | -233.00K |
| Issuance of Common Stock | -- | -- | 17.00K | 23.84M | 1.00K |
| Repurchase of Common Stock | -1.16M | -171.00K | -133.00K | -385.00K | -589.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | -435.00K | 2.40M | -- |
| Cash from Financing | -1.39M | -402.00K | -6.78M | 12.52M | 1.09M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.36M | 2.85M | -4.04M | 3.94M | -2.94M |